A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯醌类(Benzoquinones);细胞系, 肿瘤(Cell Line, Tumor);队列研究(Cohort Studies);脱氧胞苷(Deoxycytidine);女(雌)性(Female);HSP70热休克蛋白质类(HSP70 Heat-Shock Proteins);HSP90热休克蛋白质类(HSP90 Heat-Shock Proteins);人类(Humans);内酰胺类, 大环(Lactams, Macrocyclic);中年人(Middle Aged);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);卵巢肿瘤(Ovarian Neoplasms);腹膜肿瘤(Peritoneal Neoplasms);存活率(Survival Rate)
DOI
10.1016/j.ygyno.2011.10.002
PMID
22047770
发布时间
2024-06-15
- 浏览22

Gynecologic oncology
210-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文